P01.019 Blood derived exosomal hTERT mRNA in glioblastoma: A potential circulating biomarker
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

P01.019 Blood derived exosomal hTERT mRNA in glioblastoma: A potential circulating biomarker

Uziel, O;Beery, E;Lahav, M;Abu Shkara, R;Yust-Katz, S;Amiel, A;Kanner, A A;Laviv, Y;Ben Zvi, I;Siegal, T;
Neuro-Oncology 2018 Vol. 20 pp. iii232-iii232
61
o2018neuro-oncologyp01.019

Abstract

AbstractBackground. Primary glioblastoma multiforme (GBM) have a high proportion (~80%) of TERT-expressing tumors, indicating that this is the primary mechanism

Keywords

Access

URL:
https://doi.org/10.1093/neuonc/noy139.061

Citation

ID: 273962
Ref Key: o2018neuro-oncologyp01.019
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
273962
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store